Ketryx raised $14M in their Series A from Lightspeed Venture Partners. Then they hired Wizardly. We rebuilt the brand, rewrote the messaging, designed the Series B pitch deck, flew to Boston, and helped launch a campaign that landed them Transformation Capital as their lead investor — and $39M in Series B funding.
From Series A startup to Series B credibility. In 3 months.
When Ketryx came to Wizardly, they had a $14M Series A, a product trusted by three of the top five global medtech companies, and a website that didn't match any of it. The compliance platform powering FDA-regulated AI for 25 million patients a year was being represented by a brand that looked like it was still in stealth mode.
Over a 3-month engagement, Wizardly delivered a complete rebrand: brand strategy, visual identity, 30 custom Figma pages (desktop + mobile), a component library, custom isometric illustrations, product dashboard redesigns, and the messaging framework that would anchor the Series B pitch.
Then we designed the pitch deck. And then we flew to Boston to produce the Series B launch campaign — ads, video content, and collateral to announce the round to the market.
The metrics that matter when brand meets fundraise.
A product trusted by Fortune 500 medtech. A brand that didn't show it.
Ketryx's platform was already being used by three of the top five global medtech companies. Customers like Beacon Biosignals had achieved two-week release cycles and two FDA approvals using the platform. Heartflow reduced complexity by 90%. DeepHealth deployed four FDA-approved AI diagnostic products.
But the brand and website didn't project that enterprise credibility. Ketryx needed to look like what it already was — the compliance infrastructure layer for regulated AI.
During brand discovery, Wizardly uncovered the core metaphor: medical device compliance is a maze for developers. Ketryx pulls them out and puts them on a conveyor belt — the streamlined manufacturing lifecycle that their platform enables. That metaphor shaped every visual and messaging decision that followed.
Brand system. Website. Pitch deck. Launch campaign.
The engagement covered four workstreams, each feeding the next. The brand system informed the website. The website informed the deck. The deck informed the launch.
$39M raised. 14 days to close. A former Medtronic CEO invested.
Ketryx announced the Series B on September 4, 2025. The round was led by Transformation Capital, with continued backing from Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations. Bill Hawkins, former CEO of Medtronic, joined as a new investor.
The announcement made noise.
The Series B was covered across major medtech and venture publications — each story leading with the brand position and messaging Wizardly helped craft.
| Publication | Headline |
|---|---|
| MedTech Dive | AI firm Ketryx raises $39M, adds former Medtronic CEO as investor |
| PRNewswire | Ketryx Raises $39M Series B Round to Power the Future of Regulated AI |
| MedCity News | AI compliance platform Ketryx raises $39M Series B |
| Medical Design & Outsourcing | Ketryx raises $39M Series B funding |
| Sourcery VC | BREAKING: Ketryx Raises $39M — Closed in Just 14 Days |
What worked — and what to watch.
We don't cherry-pick. Here's the full picture.
What Worked
Brand strategy, website, deck design, and launch campaign all executed as a single coherent system. The investor narrative started with brand discovery and carried through to press release.
14 days from pitch to signed term sheet. When your brand, product, and market story are aligned, due diligence moves faster because the company looks like what it is.
The same company that powers FDA compliance for 3 of the top 5 medtech companies now has a brand that projects that scale. The maze-to-conveyor-belt metaphor translates complex compliance into an accessible, empowering story.
Coverage in MedTech Dive, MedCity News, PRNewswire, and multiple VC publications. The Series B announcement wasn't just a press release — it was a brand event.
What to Watch
You can't A/B test a fundraise. The brand, deck, and campaign supported the raise — but Ketryx's product, team, and traction were the foundation. We built the vehicle for a story that was already strong.
We have a separate data-driven case study covering Ketryx's website performance (traffic, engagement, conversions). This case study focuses specifically on the brand-to-fundraise pipeline.
With $55M+ in total funding and expansion across Boston and Vienna, the brand system will need to scale into new markets, new personas, and enterprise sales materials. The foundation is built — now it needs to grow.
The launch campaign (ads, video, collateral) was produced to support the announcement, but we don't have performance data on those specific assets yet. Worth tracking for future campaigns.
Is your brand ready for your next round?
Investors form opinions about your company before the first slide. If your brand doesn't project the credibility your product deserves, the conversation starts at a disadvantage.
Start a ProjectSeries B announced September 4, 2025. Round details from Ketryx press release and Sourcery VC reporting.
14-day close timeline reported by Sourcery VC. Investor participation confirmed via PRNewswire.
Wizardly scope: brand strategy, visual identity, web design (30 pages), web development, illustrations, pitch deck design, messaging, launch campaign (ads, video, collateral).
Prepared by Wizardly · wizardly.co
See the work behind the numbers.
The results don’t happen without great design. Take a look at the visuals we created for Ketryx during this project.
